In October last year, the US Food and Drug Administration approved the ExAblate MRI-guided focused ultrasound technology for the treatment of pain associated with cancer metastasis to bones, which is obviously a potential benefit for men with late stage, metastatic prostate cancer. However, The “New” Prostate Cancer InfoLink was conscious, when we first heard of […]Image may be NSFW.
Clik here to view.
Clik here to view.
